Your browser doesn't support javascript.
loading
Effectiveness of inactivated and Ad5-nCoV COVID-19 vaccines against SARS-CoV-2 Omicron BA. 2 variant infection, severe illness, and death.
Huang, Zhuoying; Xu, Shuangfei; Liu, Jiechen; Wu, Linlin; Qiu, Jing; Wang, Nan; Ren, Jia; Li, Zhi; Guo, Xiang; Tao, Fangfang; Chen, Jian; Lu, Donglei; Sun, Xiaodong; Wang, Weibing.
Afiliación
  • Huang Z; Institute of Immunization, Shanghai Municipal Center of Disease Control and Prevention, 1380 Western Zhongshan Road, Shanghai, 200336, China.
  • Xu S; Shanghai Institute of Infectious Disease and Biosecurity, School of Public Health, Fudan University, 138 Yi Xue Yuan Road, Shanghai, 200032, China.
  • Liu J; Institute of Immunization, Shanghai Municipal Center of Disease Control and Prevention, 1380 Western Zhongshan Road, Shanghai, 200336, China.
  • Wu L; Institute of Immunization, Shanghai Municipal Center of Disease Control and Prevention, 1380 Western Zhongshan Road, Shanghai, 200336, China.
  • Qiu J; Institute of Immunization, Shanghai Municipal Center of Disease Control and Prevention, 1380 Western Zhongshan Road, Shanghai, 200336, China.
  • Wang N; Institute of Immunization, Shanghai Municipal Center of Disease Control and Prevention, 1380 Western Zhongshan Road, Shanghai, 200336, China.
  • Ren J; Institute of Immunization, Shanghai Municipal Center of Disease Control and Prevention, 1380 Western Zhongshan Road, Shanghai, 200336, China.
  • Li Z; Institute of Immunization, Shanghai Municipal Center of Disease Control and Prevention, 1380 Western Zhongshan Road, Shanghai, 200336, China.
  • Guo X; Institute of Immunization, Shanghai Municipal Center of Disease Control and Prevention, 1380 Western Zhongshan Road, Shanghai, 200336, China.
  • Tao F; Institute of Infectious Diseases, Shanghai Municipal Center of Disease Control and Prevention, Shanghai, 200336, China.
  • Chen J; Institute of Infectious Diseases, Shanghai Municipal Center of Disease Control and Prevention, Shanghai, 200336, China.
  • Lu D; Division of Health Risk Factors Monitoring and Control, Shanghai Municipal Center of Disease Control and Prevention, Shanghai, 200336, China.
  • Sun X; Institute of Immunization, Shanghai Municipal Center of Disease Control and Prevention, 1380 Western Zhongshan Road, Shanghai, 200336, China. sunxiaodong@scdc.sh.cn.
  • Wang W; Shanghai Institute of Infectious Disease and Biosecurity, School of Public Health, Fudan University, 138 Yi Xue Yuan Road, Shanghai, 200032, China. wwb@fudan.edu.cn.
BMC Med ; 20(1): 400, 2022 10 20.
Article en En | MEDLINE | ID: mdl-36266697
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Vacunas Virales / COVID-19 Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: BMC Med Asunto de la revista: MEDICINA Año: 2022 Tipo del documento: Article País de afiliación: China Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Vacunas Virales / COVID-19 Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: BMC Med Asunto de la revista: MEDICINA Año: 2022 Tipo del documento: Article País de afiliación: China Pais de publicación: Reino Unido